Paul Bisaro is Director of Zoetis Inc.. Currently has a direct ownership of 20,319 shares of ZTS, which is worth approximately $3.59 Million. The most recent transaction as insider was on Feb 08, 2024, when has been sold 1,493 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 20.3K
0% 3M change
7.93% 12M change
Total Value Held $3.59 Million

PAUL BISARO Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 08 2024
BUY
Exercise of conversion of derivative security
-
1,493 Added 6.84%
20,319 Common Stock
Feb 11 2023
BUY
Exercise of conversion of derivative security
-
1,626 Added 7.95%
18,826 Common Stock
Feb 12 2022
BUY
Exercise of conversion of derivative security
-
2,673 Added 13.45%
17,200 Common Stock
Feb 13 2021
BUY
Exercise of conversion of derivative security
-
2,779 Added 16.06%
14,527 Common Stock

Also insider at

TXMD
TherapeuticsMD, Inc. Healthcare
MNKPF
Mallinckrodt plc Healthcare
MYGN
MYRIAD GENETICS INC Healthcare
PB

Paul Bisaro

Director
Hazelwood, MO

Track Institutional and Insider Activities on ZTS

Follow Zoetis Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ZTS shares.

Notify only if

Insider Trading

Get notified when an Zoetis Inc. insider buys or sells ZTS shares.

Notify only if

News

Receive news related to Zoetis Inc.

Track Activities on ZTS